Proteins and Peptides
12 December 2018
Levo Therapeutics Announces Initiation of the CARE-PWS Phase 3 Study of Intranasal Carbetocin for the Treatment of Prader-Willi Syndrome11 December 2018
Ra Pharmaceuticals Announces Positive Top-line Data from Phase 2 Trial of Zilucoplan in Patients with Generalized Myasthenia Gravis5 December 2018
CERENIS Announces the Results of TANGO, a Phase III Clinical Study Evaluating CER-001 in Patients with HDL Deficiency4 December 2018
Revance’s RT002 Demonstrates Unprecedented Efficacy and Duration In Largest-Ever Aesthetic Neuromodulator Clinical Program4 December 2018
Biotest AG takes next step in developing a new haemophilia therapeutic to target patient needs28 November 2018
Constant Pharmaceuticals to Initiate Clinical Development of TXA127 for Epidermolysis Bullosa (EB)28 November 2018
Protagonist Therapeutics Announces New Development Candidate PN-10943 for the Treatment of Inflammatory Bowel Disease28 November 2018
PhaseBio Announces Dosing of First Patient in Phase 2b Clinical Trial of PB1046 in Pulmonary Arterial Hypertension28 November 2018
Bayer receives EU approval for its hemophilia A treatment Jivi®27 November 2018
Octapharma receives Swissmedic approval for fibryga® to treat congenital and acquired fibrinogen deficiencies27 November 2018
Sandoz receives eighth European Commission approval for a biosimilar with Ziextenzo® (pegfilgrastim)26 November 2018
Immune Regulation Announces Positive Results from Phase 1 Clinical Trial of PIN2011047 November 2018
Cancer Targeted Technology Files Investigational New Drug Application for CTT1403, a Novel Radiotherapeutic Drug for Prostate Cancer7 November 2018
Otonomy Presents Data Highlighting Potential of OTO-413, an Otic Sustained-Exposure Formulation of BDNF, to Treat Hearing Loss7 November 2018
Endo Announces Positive Results from Phase 3 Studies of Collagenase Clostridium Histolyticum (CCH) in Patients with Cellulite3 November 2018
U.S. FDA Approves UDENYCA™ (pegfilgrastim-cbqv)News Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports